Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The JenaValve ALIGN-AR LVAD Registry

NCT: NCT06594705 · RECRUITING

NCT IDNCT06594705
StatusRECRUITING
Start Date2024-12-09
Completion2027-08

Brief Summary

To evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated for TAVR

Frequently Asked Questions

What is The JenaValve ALIGN-AR LVAD Registry?

The JenaValve ALIGN-AR LVAD Registry is a clinical trial registered under NCT06594705. Current status: RECRUITING.

What is the status of NCT06594705?

The current status of NCT06594705 (The JenaValve ALIGN-AR LVAD Registry) is: RECRUITING.

When did The JenaValve ALIGN-AR LVAD Registry start?

The JenaValve ALIGN-AR LVAD Registry started on 2024-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.